Joel Greenblatt Neogenomics Inc Transaction History

Gotham Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$11.67 - $20.73 $19,722 - $35,033	1,690 Added 15.26%	12,765 $206,000
Q3 2023 Nov 14, 2023	SELL	$12.15 - $17.85 $389,917 - $572,842	-32,092 Reduced 74.34%	11,075 $136,000
Q2 2023 Aug 14, 2023	BUY	$14.1 - $19.83 $453,611 - $637,950	32,171 Added 292.57%	43,167 $693,000
Q1 2023 May 15, 2023	BUY	$9.09 - $19.45 $99,953 - $213,872	10,996 New	10,996 $191,000
Q1 2019 May 15, 2019	SELL	$12.14 - $20.46 $283,808 - $478,313	-23,378 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$11.24 - $18.5 $262,768 - $432,493	23,378 New	23,378 $295,000
Q3 2018 Nov 14, 2018	SELL	$12.5 - $15.38 $137,800 - $169,549	-11,024 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$7.99 - $14.05 $88,081 - $154,887	11,024 New	11,024 $145,000

295

125M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.06B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.